Resistance to Neoadjuvant Treatment in Breast Cancer: Clinicopathological and Molecular Predictors

Resistance to Neoadjuvant Treatment in Breast Cancer: Clinicopathological and Molecular Predictors

Neoadjuvant Chemotherapy (NAC) in Breast Cancer (BC) has proved useful for the reduction in tumor burden prior to surgery, allowing for a more extensive breast preservation and the eradication of subjacent micrometastases. However, the impact on prognosis is highly dependent on the establishment of...

Full description

Bibliographic Details
Main Authors: María Rosario Chica-Parrado, Ana Godoy-Ortiz, Begoña Jiménez, Nuria Ribelles, Isabel Barragan, Emilio Alba
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Cancers
Subjects:
breast cancer
neoadjuvant chemotherapy
pathological complete response
predictive markers
residual disease
Online Access:https://www.mdpi.com/2072-6694/12/8/2012

Similar Items

Similar Items